Correlation Between Akero Therapeutics and Uniqure NV
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Uniqure NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Uniqure NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Uniqure NV, you can compare the effects of market volatilities on Akero Therapeutics and Uniqure NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Uniqure NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Uniqure NV.
Diversification Opportunities for Akero Therapeutics and Uniqure NV
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akero and Uniqure is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Uniqure NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniqure NV and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Uniqure NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniqure NV has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Uniqure NV go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Uniqure NV
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.73 times more return on investment than Uniqure NV. However, Akero Therapeutics is 1.36 times less risky than Uniqure NV. It trades about 0.01 of its potential returns per unit of risk. Uniqure NV is currently generating about -0.02 per unit of risk. If you would invest 5,166 in Akero Therapeutics on August 31, 2024 and sell it today you would lose (1,956) from holding Akero Therapeutics or give up 37.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Uniqure NV
Performance |
| Timeline |
| Akero Therapeutics |
| Uniqure NV |
Akero Therapeutics and Uniqure NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Uniqure NV
The main advantage of trading using opposite Akero Therapeutics and Uniqure NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Uniqure NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniqure NV will offset losses from the drop in Uniqure NV's long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Uniqure NV vs. Rocket Pharmaceuticals | Uniqure NV vs. Rhythm Pharmaceuticals | Uniqure NV vs. Solid Biosciences LLC | Uniqure NV vs. MeiraGTx Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |